Arkenau, H.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Current filamentation in bipolar power devices during dynamic avalanche breakdown

J Oetjen, R Jungblut, U Kuhlmann, J Arkenau, R Sittig

Journal:

Solid-State Electronics

Year:

2000

Language:

english

File:

PDF, 356 KB

english, 2000

2

5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial

Journal:

Annals of Oncology

Year:

2003

Language:

english

File:

PDF, 97 KB

english, 2003

3

How medical students use World Wide Web resources at a German medical school

Claudius Diez, Cord Arkenau, Friederike Meyer-Wentrup

Journal:

Medical Education

Year:

2000

Language:

english

File:

PDF, 35 KB

english, 2000

4

Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER)

Cho, Eun-Ae, Moloney, Fergal J, Cai, Hong, Au-Yeung, Annie, China, Carlos, Scolyer, Richard A, Yosufi, Benafsha, Raftery, Mark J, Deng, Jason Z, Morton, Stephen W, Hammond, Paula T, Arkenau, Hendrik-T

Journal:

Year:

2013

Language:

english

File:

PDF, 2.00 MB

english, 2013

5

Clinical Impact of Checkpoint Inhibitors as Novel Cancer Therapies

Shih, Kent, Arkenau, Hendrik-Tobias, Infante, Jeffrey R.

Journal:

Year:

2014

Language:

english

File:

PDF, 721 KB

english, 2014

6

Prospective Validation of a Prognostic Score to Improve Patient Selection for Oncology Phase I Trials

Arkenau, H.-T., Barriuso, J., Olmos, D., Ang, J. E., de Bono, J., Judson, I., Kaye, S.

Journal:

Journal of Clinical Oncology

Year:

2009

Language:

english

File:

PDF, 105 KB

english, 2009

7

931OA phase IIa study of tisotumab vedotin (HuMax®-TF-ADC) in patients with relapsed, recurrent and/or metastatic cervical cancer

Vergote, I., Dean, E., Lassen, U., de Bono, J., Drew, Y., Machiels, J-P., Nielsen, D., Arkenau, H-T., Forster, M., Jones, R., Slomovitz, B., Spicer, J., Johnson, M., Cornez, N., Gennigens, C., Fulton,

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 92 KB

english, 2017

8

963PA phase IIa study of tisotumab vedotin in patients with previously treated recurrent or metastatic cervical cancer: Updated analysis of full cervical expansion cohort

Concin, N, Vergote, I B, Lassen, U N, Drew, Y, Machiels, J-P, Arkenau, H-T, Forster, M D, Jones, R, Johnson, M L, Slomovitz, B M, Spicer, J, Cornez, N, Gennigens, C, Coleman, R L, Windfeld, K, Ghatta,

Journal:

Annals of Oncology

Year:

2018

Language:

english

File:

PDF, 79 KB

english, 2018

9

Tisotumab vedotin (TV) in patients with previously treated recurrent or metastatic cervical cancer: Updated safety and efficacy results from the full cervical cohort of the phase II innova TV 201 study (NCT02001623)

Hong, D.S., Arkenau, H.T., de Bono, J., Lassen, U.N., Drew, Y., Slomovitz, B.M., Ghatta, S., Windfeld, K., Rangwala, R.A., Concin, N.

Journal:

Gynecologic Oncology

Year:

2019

Language:

english

File:

PDF, 84 KB

english, 2019

10

The Body Image Matrix of Thinness and MuscularityâMale Bodies: Development and validation of a new figure rating scale for body image in men

Arkenau, Rike, Vocks, Silja, Taube, Christoph O., Waldorf, Manuel, Hartmann, Andrea S.

Journal:

Journal of Clinical Psychology

Year:

2020

Language:

english

File:

PDF, 818 KB

english, 2020

11

A systematic review and meta-analysis of PD-1/PD-L1 inhibitors in specific patient subgroups with advanced gastro-oesophageal junction and gastric adenocarcinoma

Formica, V., Morelli, C., Patrikidou, A., Shiu, KK., Nardecchia, A., Lucchetti, J., Roselli, M., Arkenau, HT.

Journal:

Critical Reviews in Oncology/Hematology

Year:

2021

File:

PDF, 4.64 MB

2021

12

Reporting time-to-event endpoints and response rates in 4 decades of randomized controlled trials in advanced colorectal cancer

Hendrik-Tobias Arkenau, Ina Nordman, Timothy Dobbins, Robyn Ward

Journal:

Year:

2011

Language:

english

File:

PDF, 244 KB

english, 2011

13

Correlation of MUC5AC immunoreactivity with histopathological subtypes and prognosis of gastric carcinoma

Stephan E. Baldus, Stefan P. Mönig, Verena Arkenau, Franz-Georg Hanisch, Paul M. Schneider, Juergen Thiele, Arnulf H. Hölscher, Hans P. Dienes

Journal:

Annals of Surgical Oncology

Year:

2002

Language:

english

File:

PDF, 1.08 MB

english, 2002

14

Ein seltener Fall von Cholestase und Makrohämaturie bei einem 52-jährigen Patienten

Hendrik-Tobias Arkenau, Adji Widjaja

Journal:

Medizinische Klinik - Intensivmedizin und Notfallmedizin

Year:

2002

Language:

german

File:

PDF, 1.68 MB

german, 2002

15

Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion

H. T. Arkenau, K. Rettig, R. Porschen

Journal:

International Journal of Colorectal Disease

Year:

2005

Language:

english

File:

PDF, 159 KB

english, 2005

16

Predictive and prognostic value of microsatellite instability in patients with advanced colorectal cancer treated with a fluoropyrimidine and oxaliplatin containing first-line chemotherapy. A report of the AIO Colorectal Study Group

C. I. Müller, K. Schulmann, A. Reinacher-Schick, N. Andre, D. Arnold, A. Tannapfel, H. Arkenau, S. A. Hahn, S. H.-J. Schmoll, R. Porschen, W. Schmiegel, U. Graeven

Journal:

International Journal of Colorectal Disease

Year:

2008

Language:

english

File:

PDF, 183 KB

english, 2008

17

Gastric cancer in the era of molecularly targeted agents: current drug development strategies

Hendrik-Tobias Arkenau

Journal:

Journal of Cancer Research and Clinical Oncology

Year:

2009

Language:

english

File:

PDF, 399 KB

english, 2009

18

The feasibility of using topotecan, vinorelbine, thiotepa and gemcitabine (TVTG) in adult patients with relapsed/refractory acute lymphoblastic leukaemia/lymphoma

Hiwarkar, P, Arkenau, H-T, Treleaven, J, Morgan, G, Potter, M, Ethell, M

Journal:

Year:

2008

Language:

english

File:

PDF, 82 KB

english, 2008

19

Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial

Nehls, O, Klump, B, Arkenau, H T, Hass, H G, Greschniok, A, Gregor, M, Porschen, R

Journal:

British Journal of Cancer

Year:

2002

Language:

english

File:

PDF, 57 KB

english, 2002

20

Reply: Clinical outcome and prognostic factors for patients treated within a phase I study: the Royal Marsden Hospital Experience

Olmos, D, Arkenau, H-T, Ang, J E, de Bono, J S, Judson, I, Kaye, S B

Journal:

British Journal of Cancer

Year:

2008

Language:

english

File:

PDF, 41 KB

english, 2008

21

The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study

Molife, L R, Fong, P C, Paccagnella, L, Reid, A H M, Shaw, H M, Vidal, L, Arkenau, H-T, Karavasilis, V, Yap, T A, Olmos, D

Journal:

British Journal of Cancer

Year:

2010

Language:

english

File:

PDF, 469 KB

english, 2010

22

Targeting BRAF for patients with melanoma

Arkenau, H-T, Kefford, R, Long, G V

Journal:

British Journal of Cancer

Year:

2010

Language:

english

File:

PDF, 334 KB

english, 2010

23

Targeted agents in cancer therapy

Hendrik-Tobias Arkenau, Craig P. Carden, Johann S. de Bono

Journal:

Medicine (Medicine Publishing Company Ltd)

Year:

2008

Language:

english

File:

PDF, 183 KB

english, 2008

24

Identification of factors limiting patient recruitment into phase I trials: A study from the Royal Marsden Hospital

Vasilios Karavasilis, Laurence Digue, Tobias Arkenau, David Eaton, Sarah Stapleton, Johann de Bono, Ian Judson, Stan Kaye

Journal:

European Journal of Cancer

Year:

2008

Language:

english

File:

PDF, 127 KB

english, 2008

25

90-Days mortality rate in patients treated within the context of a phase-I trial: How should we identify patients who should not go on trial?

Hendrik-Tobias Arkenau, David Olmos, Joo Ern Ang, Jorge Barriuso, Vasilios Karavasilis, Sue Ashley, Johann de Bono, Ian Judson, Stan Kaye

Journal:

European Journal of Cancer

Year:

2008

Language:

english

File:

PDF, 243 KB

english, 2008

26

A study of the pattern of hospital admissions in a specialist Phase I oncology trials unit: Unplanned admissions as an early indicator of patient attrition

Andre T. Brunetto, Joo Ern Ang, David Olmos, Daniel Tan, Jorge Barriuso, Hendrik-Tobias Arkenau, Timothy A. Yap, L. Rhoda Molife, Udai Banerji, Johann de Bono, Ian Judson, Stan Kaye

Journal:

European Journal of Cancer

Year:

2010

Language:

english

File:

PDF, 188 KB

english, 2010

27

Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial

Gerald S Falchook, Georgina V Long, Razelle Kurzrock, Kevin B Kim, Tobias H Arkenau, Michael P Brown, Omid Hamid, Jeffrey R Infante, Michael Millward, Anna C Pavlick, Steven J O’Day, Samuel C Blackman

Journal:

Year:

2012

Language:

english

File:

PDF, 576 KB

english, 2012

28

49 POSTER Analyses of pharmacodynamic (PD) assessments collected during expanded cohorts (EC) of a phase I trial with OSI-930, a multi-targeted oral tyrosine kinase inhibitor (TKI)

J. Spratlin, H.T. Arkenau, S. George, N.J. Serkova, M. Germuska, K. Brock, R. Gedrich, M. Scurr, G.D. Demetri, D.R. Camidge

Journal:

European Journal of Cancer Supplements

Year:

2008

Language:

english

File:

PDF, 58 KB

english, 2008

29

1235 A phase-I study of the combination of intravenous reovirus (REOLYSIN ®) and gemcitabine in patients with advanced cancer

M.P. Lolkema, K. Harrington, J. Evans, H.T. Arkenau, P. Roxburgh, R. Morrison, V. Roulstone, M. Coffey, K. Mettinger, J. de Bono

Journal:

European Journal of Cancer Supplements

Year:

2009

Language:

english

File:

PDF, 51 KB

english, 2009

30

Oxaliplatin in Combination with 5-Fluorouracil/Leucovorin or Capecitabine in Elderly Patients with Metastatic Colorectal Cancer

Hendrik-Tobias Arkenau, Ullrich Graeven, Stephan Kubicka, Axel Grothey, Christina Englisch-Fritz, Albrecht Kretzschmar, Richard Greil, Werner Freier, Thomas Seufferlein, Axel Hinke, Hans-Joachim Schmo

Journal:

Clinical Colorectal Cancer

Year:

2008

Language:

english

File:

PDF, 116 KB

english, 2008

31

Current Treatment Strategies in Elderly Patients with Metastatic Colorectal Cancer

Hendrik-Tobias Arkenau, Yu Jo Chua, David Cunningham

Journal:

Clinical Colorectal Cancer

Year:

2007

Language:

english

File:

PDF, 145 KB

english, 2007

32

Prognostic Value of Reduced SMAD4 Expression in Patients With Metastatic Colorectal Cancer Under Oxaliplatin-Containing Chemotherapy: A Translational Study of the AIO Colorectal Study Group

Alexander Baraniskin, Johanna Munding, Karsten Schulmann, Dominik Meier, Rainer Porschen, Hendrik-Tobias Arkenau, Ullrich Graeven, Wolff Schmiegel, Andrea Tannapfel, Anke Reinacher-Schick

Journal:

Clinical Colorectal Cancer

Year:

2011

Language:

english

File:

PDF, 492 KB

english, 2011

33

Opioid extended-release tablets with improved tamper-resistant properties

Bartholomaeus, Johannes H, Arkenau-Marić, Elisabeth, Galia, Eric

Journal:

Expert Opinion on Drug Delivery

Year:

2012

Language:

english

File:

PDF, 628 KB

english, 2012

34

Combination Molecularly Targeted Drug Therapy in Metastatic Melanoma: Progress to Date

Lemech, Charlotte, Infante, Jeffrey, Arkenau, Hendrik-Tobias

Journal:

Year:

2013

Language:

english

File:

PDF, 417 KB

english, 2013

35

The future is here: tumour profiling in day-to-day clinical practice

Lemech, Charlotte R., Arkenau, Hendrik-Tobias

Journal:

Drug Discovery Today

Year:

2013

Language:

english

File:

PDF, 163 KB

english, 2013

36

610 Loss of the Tumor Suppressor Merlin as a Potential Predictive Biomarker of Clinical Activity for the Oral, Focal Adhesion Kinase (FAK) Inhibitor GSK2256098 in Pts with Recurrent Mesothelioma

Soria, J.C., Plummer, R., Ranson, M., Gan, H., Arkenau, H.T., Zalcman, G., Blagden, S., Evans, T.R.J., Peddareddigari, V., Mazumdar, J., Murray, S., Gibson, D., Fleming, R.A., Auger, K., Millward, M.

Journal:

European Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 58 KB

english, 2012

37

476 Serum Proteomic Classification in Refractory Non-small-cell Lung Cancer Treated with Erlotinib +/− Pazopanib in a Randomized Placebo-controlled Phase II Study

Spigel, D.R., Burris, H.A., Greco, F.A., Lipman, A.J., Waterhouse, D.M., Daniel, D.B., Ma, Z., Arkenau, H.T., Grigorieva, J., Hainsworth, J.D.

Journal:

European Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 73 KB

english, 2012

38

613 Pharmacokinetics/pharmacodynamics (PK/PD) of GSK2256098, a Focal Adhesion Kinase (FAK) Inhibitor, in Patients with Advanced Solid Tumors

Gan, H., Nebot, N., Soria, J.C., Arkenau, H.T., Blagden, S., Plummer, R., Ranson, M., Evans, T.R.J., Zalcman, G., Peddareddigari, V., Gibson, D., Murray, S., Mazumdar, J., Fleming, R., Auger, K., Mill

Journal:

European Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 60 KB

english, 2012

39

P971: Neurological outcomes following chemotherapy treatment: assessment of functional impairment, precision grip and nerve function

Park, S., Davare, M., Bridgewater, J., Hochhauser, D., Arkenau, H.-T., Koltzenburg, M.

Journal:

Clinical Neurophysiology

Year:

2014

Language:

english

File:

PDF, 67 KB

english, 2014

40

Dose Selection, Pharmacokinetics, and Pharmacodynamics of BRAF Inhibitor Dabrafenib (GSK2118436)

Falchook, G. S., Long, G. V., Kurzrock, R., Kim, K. B., Arkenau, H.- T., Brown, M. P., Hamid, O., Infante, J. R., Millward, M., Pavlick, A., Chin, M. T., O'Day, S. J., Blackman, S. C., Curtis, C. M.,

Journal:

Clinical Cancer Research

Year:

2014

Language:

english

File:

PDF, 759 KB

english, 2014

41

Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience

Arkenau, H.-T., Chong, G., Cunningham, D., Watkins, D., Sirohi, B., Chau, I., Wotherspoon, A., Norman, A., Horwich, A., Matutes, E.

Journal:

Year:

2007

Language:

english

File:

PDF, 159 KB

english, 2007

42

Mucosa associated lymphoid tissue lymphoma of the lung: The Royal Marsden Hospital experience

Arkenau, Hendrik-Tobias, Gordon, Claire, Cunningham, David, Norman, Andy, Wotherspoon, Andrew, Chau, Ian

Journal:

Leukemia and Lymphoma

Year:

2007

Language:

english

File:

PDF, 82 KB

english, 2007

43

A Phase 1 Trial of X-396, a Novel ALK Inhibitor, in Patients With Advanced Solid Tumors

Horn, L., Blumenscheine, G., Wakelee, H.A., Arkenau, T.H., Dukart, G., Harrow, K., Liang, C., Gibbons, J.J., Lovly, C.M., Infante, J.R.

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2014

Language:

english

File:

PDF, 82 KB

english, 2014

44

127 Correlation of clinical activity of pembrolizumab (MK-3475) with immunohistochemical staining for programmed death-1 ligand (PD-L1) in ≥50% of tumor cells in a prospective non-small cell lung cancer (NSCLC) validation population

Garon, E.G., Rizvi, N.A., Leighl, N.B., Hui, R., Eder, J.P., Patnaik, A., Aggarwal, C., Horn, L., Balmanoukian, A.S., Gubens, M.A., Felip-Font, E., Costa, E. Carceny, Soria, J.C., Ahn, M.J., Arkenau,

Journal:

European Journal of Cancer

Year:

2014

Language:

english

File:

PDF, 74 KB

english, 2014

45

506 Phase (Ph) 1/2a study of TSR-011, a potent inhibitor of ALK and TRK, in advanced solid tumors including crizotinib-resistant ALK positive non-small cell lung cancer

Sachdev, J., Arkenau, H.T., Infante, J.R., Mita, M.M., Anthony, S.P., Natale, R.B., Ejadi, S., Wilcoxen, K., Kansra, V., Laken, H., Hughes, L., Martell, R., Weiss, G.J.

Journal:

European Journal of Cancer

Year:

2014

Language:

english

File:

PDF, 59 KB

english, 2014

46

395 cMet: Proof-of-concept clinical trial with volitinib in patients with advanced papillary renal cell cancer (PRCC)

Choueiri, T.K., Escudier, B., Pal, S. Kumar, Jonasch, E., Heng, D., Powles, T., Arkenau, H.T., Clark, E., D'Cruz, C., Frigault, M., Nash, A.F., Morgan, S.R.

Journal:

European Journal of Cancer

Year:

2014

Language:

english

File:

PDF, 99 KB

english, 2014

47

A Phase I Study of the Combination of Intravenous Reovirus Type 3 Dearing and Gemcitabine in Patients with Advanced Cancer

Lolkema, M. P., Arkenau, H.-T., Harrington, K., Roxburgh, P., Morrison, R., Roulstone, V., Twigger, K., Coffey, M., Mettinger, K., Gill, G., Evans, T. R. J., de Bono, J. S.

Journal:

Clinical Cancer Research

Year:

2011

Language:

english

File:

PDF, 337 KB

english, 2011

48

Expression of Regulators of G Protein Signaling mRNA Is Differentially Regulated in Hot and Cold Thyroid Nodules

Tönjes, Anke, Miedlich, Susanne, Holzapfel, Hans-Peter, Eszlinger, Markus, Arkenau, Cord, Paschke, Ralf

Journal:

Year:

2004

Language:

english

File:

PDF, 76 KB

english, 2004

49

Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX

Nehls, O, Okech, T, Hsieh, C-J, Enzinger, T, Sarbia, M, Borchard, F, Gruenagel, H-H, Gaco, V, Hass, H G, Arkenau, H T, Hartmann, J T, Porschen, R, Gregor, M, Klump, B

Journal:

British Journal of Cancer

Year:

2007

Language:

english

File:

PDF, 215 KB

english, 2007

50

Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience

Arkenau, H-T, Olmos, D, Ang, J E, de Bono, J, Judson, I, Kaye, S

Journal:

British Journal of Cancer

Year:

2008

Language:

english

File:

PDF, 152 KB

english, 2008